The Idiopathic Intracranial Hypertension Treatment Trial: A Review of the Outcomes
Most breast changes caused by GLP-1 use and weight loss are usually benign however you should seek assessment if you notice: A new lump or area of thickening One breast changing more than the other Skin dimpling, redness or puckering Nipple inversion or discharge Persistent pain in an area Even when changes are likely to be weight-related, imaging (ultrasound, mammography or MRI in selected cases) can provide clarity and peace of mind and also enables a new post weight-loss baseline to be established
Weightloss medications are prescriptiononly and are typically considered for adults with: BMI of 30 or higher, or BMI of 27 or higher combined with a weightrelated condition (such as diabetes, high blood pressure, high cholesterol or sleep apnea) Most weightloss drugs should be used alongside lifestyle modifications, not as a standalone strategy
Should I inject both biceps even if only the left one is lagging
Sandoval DA, DAlessio DA (2015) Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and disease
10.3389/fmicb.2018.01130 Front
